Analyst RatingAnalyst recommends maintaining a BUY rating on APM with a target price of C$3.50/share.
Financial HealthAPM has an excellent balance sheet, with $27M in net cash, allowing the Company to pursue organic growth, M&A, and share buybacks.
Financial PerformanceAPM stock trades at only 2.6x 2025E EBITDA with a long-term track record of growth and successful acquisitions.